Lumido, Percivil .

HRN: 29-14-27  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2026
CEFUROXIME 1.5GM (VIAL)
06/13/2026
06/20/2026
IV
1.5g
Q8h
CAP-MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: